Calan

   
Google
 
Web NewDrugInformation.com

Calan


Drug - Calan
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Verapamil Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 80MG
The potency of the active ingredient(s), Verapamil Hydrochloride. May repeat for multiple part products.

Applicant - GD SEARLE LLC
The firm name holding legal responsibility for Calan. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018817
The FDA assigned number to Calan. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Calan. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 10, 1984
The date Calan was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Calan. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Calan is in. Format is RX, OTC, DISCN.

Applicant Full Name - Gd Searle Llc
The full name of the firm holding legal responsibility for the new application of Calan.

Calan